Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Asthma and COPD Drugs Market to reach USD 51.92 billion by the end of 2030.

Global Asthma and COPD Drugs Market Size Study & Forecast, by Diseases (Asthma, COPD), by Medication Class (Combination Drugs, Short Acting Beta Agonists (SABA), Long Acting Beta Agonists (LABA), Leukotriene Antagonists (LTA), Anticholinergics, Others), and Regional Analysis, 2023-2030

Product Code: HLSDT-91576685
Publish Date: 4-10-2023
Page: 200

Global Asthma and COPD Drugs Market is valued at approximately USD 36.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.64% over the forecast period 2023-2030. Asthma and COPD drugs are medications used to manage and treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Both asthma and COPD are chronic respiratory diseases characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, coughing, and chest tightness. The Asthma and COPD Drugs Market is expanding because of factors such as the growing trend of personalized therapy, changing lifestyle patterns, and increasing government support, coupled with better access to healthcare services.

In addition, the increasing prevalence of asthma and COPD is acting as a catalyzing factor for market growth across the globe. Asthma and COPD are chronic respiratory diseases with a significant global burden. According to the World Health Organization (WHO), respiratory disease infection is considered the third major cause of death with approximately 3 million death per year (6% of global deaths), in which nearly 90% of COPD fatalities occur in those 70-year-old people from the low-and middle-income countries. Also, there are around 262 million patients estimated to suffer from asthma, which commonly affects children. Thus, the increasing prevalence of these conditions, driven by factors such as air pollution, smoking, aging populations, and changing lifestyles, contributes to the growing demand for effective medications to manage and treat asthma and COPD, which, in turn, propelling the growth of the Asthma and COPD Drugs Market during the estimated period. Moreover, the technological advancements in drug development, as well as the increasing awareness about asthma and COPD, along with improved diagnostic techniques present various lucrative opportunities over the forecast years. However, the side effects associated with drugs and stringent government regulations for product approvals are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Asthma and COPD Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing research and development activities, along with the rise in the number of fundings undertaken by government and non-government organizations. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rising healthcare expenditure, favorable reimbursement policies, increasing aging population, as well as favorable reimbursement policies are significantly propelling the market demand across the region.

Major market players included in this report are:
Vectura Group Limited
Abbott Laboratories
Glaxosmithkline Plc
Sanofi
Organon
F. Hoffmann-La Roche AG
Novartis AG
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd
AstraZeneca Plc

Recent Developments in the Market:
Ø In October 2022, Verona reported positive analyses of Ensifentrine, a medication used to treat chronic obstructive pulmonary disease (COPD), which was the subject of a phase 3 clinical trial. Ensifentrine combines bronchodilator and anti-inflammatory properties into a single substance.
Ø In June 2022, Glenmark introduced the innovative fixed dose combination (FDC) medication Indacaterol with Mometasone for patients in India with unmanageable asthma. This FDC was introduced by the business under the Indamet brand.

Global Asthma and COPD Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Diseases, Medication Class, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Diseases:
Asthma
COPD

By Medication Class:
Combination Drugs
Short Acting Beta Agonists (SABA)
Long Acting Beta Agonists (LABA)
Leukotriene Antagonists (LTA)
Anticholinergics
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Asthma and COPD Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Asthma and COPD Drugs Market, by Diseases, 2020-2030 (USD Billion)
1.2.3. Asthma and COPD Drugs Market, by Medication Class, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Asthma and COPD Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Asthma and COPD Drugs Market Dynamics
3.1. Asthma and COPD Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of asthma and COPD
3.1.1.2. Rising trend of personalized therapy
3.1.2. Market Challenges
3.1.2.1. Side effects associated with drugs
3.1.2.2. Stringent government regulations for product approvals
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in drug development
3.1.3.2. Increasing awareness about asthma and COPD, along with improved diagnostic techniques
Chapter 4. Global Asthma and COPD Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Asthma and COPD Drugs Market, by Diseases
5.1. Market Snapshot
5.2. Global Asthma and COPD Drugs Market by Diseases, Performance – Potential Analysis
5.3. Global Asthma and COPD Drugs Market Estimates & Forecasts by Diseases 2020-2030 (USD Billion)
5.4. Asthma and COPD Drugs Market, Sub Segment Analysis
5.4.1. Asthma
5.4.2. COPD
Chapter 6. Global Asthma and COPD Drugs Market, by Medication Class
6.1. Market Snapshot
6.2. Global Asthma and COPD Drugs Market by Medication Class, Performance – Potential Analysis
6.3. Global Asthma and COPD Drugs Market Estimates & Forecasts by Medication Class 2020-2030 (USD Billion)
6.4. Asthma and COPD Drugs Market, Sub Segment Analysis
6.4.1. Combination Drugs
6.4.2. Short Acting Beta Agonists (SABA)
6.4.3. Long Acting Beta Agonists (LABA)
6.4.4. Leukotriene Antagonists (LTA)
6.4.5. Anticholinergics
6.4.6. Others
Chapter 7. Global Asthma and COPD Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Asthma and COPD Drugs Market, Regional Market Snapshot
7.4. North America Asthma and COPD Drugs Market
7.4.1. U.S. Asthma and COPD Drugs Market
7.4.1.1. Diseases breakdown estimates & forecasts, 2020-2030
7.4.1.2. Medication Class breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Asthma and COPD Drugs Market
7.5. Europe Asthma and COPD Drugs Market Snapshot
7.5.1. U.K. Asthma and COPD Drugs Market
7.5.2. Germany Asthma and COPD Drugs Market
7.5.3. France Asthma and COPD Drugs Market
7.5.4. Spain Asthma and COPD Drugs Market
7.5.5. Italy Asthma and COPD Drugs Market
7.5.6. Rest of Europe Asthma and COPD Drugs Market
7.6. Asia-Pacific Asthma and COPD Drugs Market Snapshot
7.6.1. China Asthma and COPD Drugs Market
7.6.2. India Asthma and COPD Drugs Market
7.6.3. Japan Asthma and COPD Drugs Market
7.6.4. Australia Asthma and COPD Drugs Market
7.6.5. South Korea Asthma and COPD Drugs Market
7.6.6. Rest of Asia Pacific Asthma and COPD Drugs Market
7.7. Latin America Asthma and COPD Drugs Market Snapshot
7.7.1. Brazil Asthma and COPD Drugs Market
7.7.2. Mexico Asthma and COPD Drugs Market
7.8. Middle East & Africa Asthma and COPD Drugs Market
7.8.1. Saudi Arabia Asthma and COPD Drugs Market
7.8.2. South Africa Asthma and COPD Drugs Market
7.8.3. Rest of Middle East & Africa Asthma and COPD Drugs Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Vectura Group Limited
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summaryd
8.3.1.5. Recent Developments
8.3.2. Abbott Laboratories
8.3.3. Glaxosmithkline Plc
8.3.4. Sanofi
8.3.5. Organon
8.3.6. F. Hoffmann-La Roche AG
8.3.7. Novartis AG
8.3.8. Boehringer Ingelheim International GmbH
8.3.9. Teva Pharmaceutical Industries Ltd
8.3.10. AstraZeneca Plc
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now